Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?

Author:

Harris Adam G12,Saikal Samra L1ORCID,Scurry Jim3,Relic John1,Nixon Rosemary L4,Chee Paul12

Affiliation:

1. Department of Dermatology; John Hunter Hospital; Newcastle New South Wales Australia

2. Faculty of Medicine; University of Newcastle; Newcastle New South Wales Australia

3. Department of Anatomical Pathology; John Hunter Hospital; Newcastle New South Wales Australia

4. Occupational Dermatology Research and Education Centre; Skin and Cancer Foundation Inc.; Melbourne Victoria Australia

Publisher

Wiley

Subject

Dermatology

Reference10 articles.

1. Public Australian Register of Therapeutic Goods summaries of products containing bufexamac https://www.tga.gov.au/

2. Allergic contact dermatitis to topical preparations of bufexamac;Pan;Australas. J. Dermatol.,2012

3. EMA revokes marketing authorization for bufexamac;Uter;Contact Dermatitis,2011

4. Summary of data on the benefits and risks for bufexamac-containing medicines indicated for the relief of dermatitis, rash and hives from the minutes of the 145th Medicines Adverse Reactions Committee Meeting can be found at http://www.medsafe.govt.nz

5. Medsafe New Zealand Summary of data on the benefits and risks for bufexamac-containing medicines indicated for the relief of dermatitis, rash and hives from the minutes of the 145th Medicines Adverse Reactions Committee Meeting

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3